Cytek Biosciences Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Cytek Biosciences stock ranges from a low of $3.00 to a high of $8.00. The average analyst price target of $5.67 forecasts a 111.96% increase in the stock price over the next year.

Price Target: $5.67 (+111.96%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$3.00	$5.67	$6.00	$8.00
Change	+12.15%	+111.96%	+124.30%	+199.07%

Analyst Ratings

The average analyst rating for Cytek Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	1	1	1	0	0	0
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	1
Total	3	3	3	2	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Sykes Goldman Sachs	Goldman Sachs	Strong Sell Maintains $3.5 → $3	Strong Sell	Maintains	$3.5 → $3	+12.15%	May 12, 2025
Mason Carrico Stephens & Co.	Stephens & Co.	Buy Reiterates $6	Buy	Reiterates	$6	+124.30%	Mar 19, 2025
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $8.5 → $8	Buy	Maintains	$8.5 → $8	+199.07%	Mar 4, 2025
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $8 → $8.5	Buy	Maintains	$8 → $8.5	+217.76%	Nov 11, 2024
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $8.5 → $8	Buy	Maintains	$8.5 → $8	+199.07%	Aug 13, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

208.52M

from 200.45M

4.02%

from 200.45M

Revenue Next Year

226.19M

from 208.52M

8.47%

from 208.52M

EPS This Year

-0.05

from -0.05

EPS Next Year

-0.00

from -0.05

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	92.84M	127.95M	164.04M	193.02M	200.45M	208.52M	226.19M	258.56M
Revenue Growth	60.39%	37.82%	28.20%	17.67%	3.85%	4.02%	8.47%	14.31%
EPS	0.10	0.00	0.02	-0.09	-0.05	-0.05	-0.00	0.08
EPS Growth	-	-99.36%	2,906.28%	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	32.78
No. Analysts	-	-	-	-	-	8	8	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	218.4M	244.6M	279.6M
Avg	208.5M	226.2M	258.6M
Low	194.0M	199.6M	227.4M

Revenue Growth

Revenue Growth	2025	2026	2027
High	8.9%	17.3%	23.6%
Avg	4.0%	8.5%	14.3%
Low	-3.2%	-4.3%	0.5%

EPS Forecast

EPS	2025	2026	2027
High	-0.02	0.13	0.19
Avg	-0.05	-0.00	0.08
Low	-0.07	-0.07	0.01

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.